The global heart beat irregularity detection device market is anticipated to grow at a 4.5% CAGR, from a market size of US$ 13.4 million in 2023 to US$ 20.7 million by the end of 2033. As a result of the requirement for early identification of cardiac arrhythmia in order to provide the best care for heart patients, the market for devices that detect irregular heartbeats is anticipated to expand.
The adoption of cardiac irregularity detection technology was somewhat influenced favourably by the COVID 19 pandemic in 2020. The drop in COVID-19 cases and the continued provision of all healthcare services has impacted the market for devices that detect irregular heartbeats. In order to provide medical aid while monitoring patients’ progress, several healthcare businesses are working to improve the manufacturing capacity of heart beat irregularity detection devices.
The market for heart beat irregularity detecting devices is anticipated to grow significantly in the near future as a result of the decline in COVID-19 infections.
Request a Report Sample to Gain Comprehensive Insights!
https://www.futuremarketinsights.com/reports/sample/rep-gb-14396
The heart beat irregularity detection device market’s growth is likely to be aided by the development of technologically improved monitoring equipment, such as wireless monitors, that give the benefit of early detection. Due to expanding life expectancy and ongoing developments that have expanded their capabilities and reach, the usage of cardiac rhythm monitoring (CRM) devices has increased dramatically in recent years.
Recent advancements in CRM devices are having a beneficial influence on the rate of product acceptance in developed countries, which will help the sector grow even more. The Holter monitor category is expected to lead in terms of device. The Holter monitor segment’s expansion is attributed to an increase in illness prevalence as a result of increased intake of unhealthy foods and a hurried lifestyle, both of which has an impact on heart health and lead to cardiac blockages and arrests.
During the analysis period, the tachycardia monitoring devices sector is predicted to increase at a 6.8% CAGR based on application. Atrial tachycardia and ventricular tachycardia are two types of tachycardia. In the next years, the use of technologically improved products for illness monitoring is likely to drive up demand for heart beat irregularity detection devices.
In 2021, atrial tachycardia accounted for the bulk of the heart beat irregularity detection devices market, and it is predicted to continue to increase in the near future. The hospitals and clinics segment led the heart beat irregularity detection devices market revenue share by end-use and is expected to increase significantly during the projected period. The rising global prevalence of heart beat irregularity, along with an ageing population, is likely to push hospital admission rates for treatment.
Reach Out To Our Analyst For Prompt Assistance With Your Questions!
https://www.futuremarketinsights.com/ask-question/rep-gb-14396
The heart beat irregularity detection devices market in North America has a large revenue share. The regional heart beat irregularity detection devices market will develop as the prevalence of heart beat irregularity disorders rises, and as people become more aware of modern monitoring procedures. The presence of major heart beat irregularity detection devices market players involved in advanced device commercialization will also help to expand regional markets.
Furthermore, the regional heart beat irregularity detection devices market demand is expected to be boosted by improved healthcare infrastructure, which would lead to an increased usage of technologically sophisticated heart beat irregularity detection devices.
Key Takeaways:
- The Holter monitor segment of the heart beat irregularity detection devices market was worth more than USD 2.8 billion in 2021, and it is predicted to expand significantly during the forecast period.
- During the analysis period, the tachycardia monitoring devices sector is expected to increase at a 6.8% CAGR based on application.
- By the end of the year, the heart beat irregularity detection devices market for resting ECG devices is expected to be worth more than US$ 2.8 billion, with a CAGR of 4.6% during the projection period.
- The largest region, North America, has a high heart beat irregularity detection devices market attractiveness rating. By the end of the projected period, the heart beat irregularity detection devices market in this area is expected to be worth US$ 2,900 Million.
- During the projection period, the mobile heart beat irregularity detection devices market sector is expected to increase at a substantial rate, with a CAGR of 8.4%.
- With a 5.8% CAGR, the ventricular fibrillation segment is expected to achieve a heart beat irregularity detection devices market worth over US$ 2,500 Million.
- During the projection period in heart beat irregularity detection devices market, the hospitals segment is expected to develop at a high CAGR of 6.9%.
Competitive Landscape:
- Philips agreed to buy Cardiology, a medical technology startup focusing on combining cloud technology and artificial intelligence to enhance heart diagnostics, in November 2021. (AI). This purchase expands the company’s heart beat irregularity detection devices product line, providing revenue growth potential in the market.
- The Federal Commission for the Protection against Sanitary Risk (COFEPRIS) gave AliveCor permission to launch KardiaMobile in Mexico in February 2020. The business has teamed up with Inpharamo to roll out the medical-grade ECG across the United States. As a result, the firm has been able to extend its global reach as well as its client base.
Art of Personalization: Dive into the World of Customization with Our Report!
https://www.futuremarketinsights.com/customization-available/rep-gb-14396
Key Companies Profiled:
- Alive Cor
- Applied Cardiac Systems
- Biotronik
- Biotricity
- GE Healthcare
- iRhythm Technologies
- Koninklijke Philips N.V.
- Medtronic plc.
- Nihon Kohden Corporation
- St. Jude Medical (Abbott Laboratories)
- Welch Allyn (Hillrom Services, Inc.)
- NUUBO Smart Solutions Technologies, SL
- Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
- Fukuda Denshi Co., Ltd.
- Schiller AG
- Mortara Instrument Inc.
- BPL Medical Technologies
- Lepu Medical Technology(Beijing) Co., Ltd
Key Segments Covered in Heart Beat Irregularity Detection Device Industry Research:
Devices:
- Holter Monitor
- Event Recorder
- Mobile Cardiac Telemetry
- Implantable Cardiac Monitor
- Electrocardiogram
- Others
Applications:
- Tachycardia
- Atrial Tachycardia
- Ventricular Tachycardia
- Bradycardia
- Premature Contraction
- Others
End-User:
- Hospitals and Clinics
- Diagnostic Centers
- Ambulatory Surgical Centers
- Homecare Settings
- Others
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
To Available Discount on Report, Click! https://www.futuremarketinsights.com/checkout/14396
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube